[{"address1": "2 Burlington Woods Drive", "address2": "Suite 100", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "781 552 4452", "website": "https://www.bonebiologics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jeffrey  Frelick", "age": 56, "title": "CEO & President", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": 337750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Deina H. Walsh", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 218875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shun'ichi  Kuroda", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.889, "open": 0.9404, "dayLow": 0.8845, "dayHigh": 1.02, "regularMarketPreviousClose": 0.889, "regularMarketOpen": 0.9404, "regularMarketDayLow": 0.8845, "regularMarketDayHigh": 1.02, "beta": 0.509, "volume": 2, "regularMarketVolume": 2, "averageVolume": 2618, "averageVolume10days": 900, "averageDailyVolume10Day": 900, "bid": 0.35, "ask": 9.0, "bidSize": 900, "askSize": 800, "fiftyTwoWeekLow": 0.018, "fiftyTwoWeekHigh": 44.145, "fiftyDayAverage": 3.8739, "twoHundredDayAverage": 2.472825, "currency": "USD", "profitMargins": 0.0, "floatShares": 2802271, "bookValue": -1.191, "netIncomeToCommon": -6505386, "trailingEps": -0.144, "52WeekChange": 16.78, "SandP52WeekChange": 0.15381551, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BBLGW", "underlyingSymbol": "BBLGW", "shortName": "BONE BIOLOGICS CORP C/WTS (TO P", "longName": "Bone Biologics Corporation", "firstTradeDateEpochUtc": 1634131800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "42b4cb99-4dca-3466-8e64-a3e9fa1107f6", "messageBoardId": "finmb_99330767", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.889, "recommendationKey": "none", "totalCash": 4452586, "totalCashPerShare": 1.421, "totalDebt": 0, "quickRatio": 3.763, "currentRatio": 4.206, "returnOnAssets": -1.17361, "returnOnEquity": -1.58772, "freeCashflow": -6283736, "operatingCashflow": -9488680, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null}]